COMP <GO>
OBIO vs CRON // EV/EBITDA & P/E VALUATION
Orchestra BioMed Holdings Inc. (NASDAQ) VS. Cronos Group Inc. Common Share (NASDAQ) • 15-METRIC TALLY: OBIO 3
— CRON 7
■ METRIC PARITY
LAST: $6.09 (+1.67%) • MKT CAP: $366.0M
valuation
—
LAST: $3.36 (+0.30%) • MKT CAP: $1.24B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OBIO VS. CRON)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OBIO | CRON | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | 42.80% | +53.20 | OBIO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -4.50% | -30.50 | CRON | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -13.51% | 0.01% | -13.52 | CRON | /fcf-yield <GO> |
| Operating Margin | -60.00% | -11.90% | -48.10 | CRON | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -2.00% | -58.00 | CRON | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 24.60% | +155.40 | OBIO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 15.20 | -15.00 | CRON | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 6/9 | -1.00 | CRON | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.6 | 50.4 | +3.20 | OBIO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $366.0M | $1.24B | -$871.8M | CRON | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OBIO REV | CRON REV | OBIO GROSS % | CRON GROSS % | OBIO FCF | CRON FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $33.5M | $146.6M | 98.0% | 42.8% | -$49.5M | $149.0K |
| FY 2024 | $2.6M | $117.6M | 92.3% | 21.4% | -$50.8M | $6.4M |
| FY 2023 | $2.8M | $87.2M | — | — | -$46.1M | -$42.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OBIO // BETA —
CRON // BETA —